AstraZeneca PLC (OTC Pink - Current Information:AZNCF)

98.91
Delayed Data
As of Jan 24
 0.00 / 0.00%
Today’s Change
69.40
Today|||52-Week Range
102.50
-2.07%
Year-to-Date
Where Will Intercept Pharmaceuticals Be in 5 Years?
Jan 23 / MotleyFool.com - Paid Partner Content
5 Reasons 2020 Will Be a Big Year for Ionis Pharmaceuticals
Jan 16 / MotleyFool.com - Paid Partner Content
Should Investors Be Worried About Merck's Keytruda?
Jan 23 / MotleyFool.com - Paid Partner Content
High Drug Prices Remains a Top Issue in Democratic Debates
Jan 15 / MotleyFool.com - Paid Partner Content
England Officially Rejects AstraZeneca's Lung Cancer Drug
Jan 22 / MotleyFool.com - Paid Partner Content
Here's Why Clovis Oncology Rose as Much as 25.6% Today
Jan 15 / MotleyFool.com - Paid Partner Content
AstraZeneca and Merck Get an FDA Priority Review for Lynparza in Prostate Cancer
Jan 21 / MotleyFool.com - Paid Partner Content
FDA Gives Clovis Oncology's Rubraca a Priority Review
Jan 15 / MotleyFool.com - Paid Partner Content
2 Biotechs Battling Immune Diseases
Jan 19 / MotleyFool.com - Paid Partner Content
Good News for Amarin: AstraZeneca Abandoning its Fish Oil Pill
Jan 13 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close98.91
Today’s open99.40
Day’s range98.91 - 99.40
Volume299
Average volume (3 months)4,893
Market cap$129.8B
Data as of 3:31pm ET, 01/24/2020

Growth & Valuation

Earnings growth (last year)-28.23%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-1.67%
P/E ratio48.5
Price/Sales4.29
Price/Book10.05

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$22.1B
Annual profit (last year)$2.2B
Net profit margin9.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts